Exelon Corporation heads into its May 6 Q1 earnings call with a notably cooler Street and a short interest count that has been quietly building for six weeks.
The most striking development this week was an unusually concentrated burst of analyst downgrades. Jefferies cut its rating from Buy to Hold on April 20, trimming its target from $55 to $50. The following day, Morgan Stanley lowered its target from $56 to $55 while holding at Equal-Weight. That same morning, Truist initiated coverage with a Hold and a $50 target. In the week prior, Barclays and BMO Capital both downgraded the stock — Barclays from Overweight to Equal-Weight, BMO from Outperform to Market Perform — and both cut their targets. Five rating actions in eight trading days, almost all pointing the same direction, is a meaningful shift in Street sentiment. The consensus mean target is now $50.22, roughly 7% above Tuesday's $47.02 close, but the direction of travel is clearly downward. RBC Capital held its Sector Perform rating while cutting to $48, the tightest target on the list. Keybanc, already at Underweight, shaved its target to $43 — the only analyst openly below the current price.
Short interest has been drifting higher in step with the analyst retreats, though the level itself is not alarming. The float short has climbed from roughly 3.94% in mid-March to 4.15% now — a steady, six-week grind rather than a sudden accumulation. The borrow market remains relaxed. Cost to borrow is running at 0.45% APR, elevated only marginally over the past week. Availability has not tightened in any meaningful way, and the lending pool shows no signs of stress. Options sentiment is similarly measured: the put/call ratio edged up to 0.44 on April 29, nudging about one standard deviation above its 20-day average of 0.42, but remains well below the 52-week peak of 0.88. Options traders are not yet positioned for a sharp move.
The bulls point to Exelon's regulated transmission footprint, which commands a Federal Energy Regulatory Commission return on equity near 10.5%, and to ComEd's year-over-year earnings growth from positive distribution timing. The bears focus on rate-case risk, a cautious capital expenditure posture, and the sensitivity of utility valuations to interest rates. At a P/E near 16x and EV/EBITDA around 9.9x, neither multiple looks stretched in isolation — the P/E is down about half a point over the past month — but they reflect a stock the Street increasingly views as fairly valued at best. The dividend score ranks in the 93rd percentile, so income-oriented holders have a clear anchor; the EPS momentum score at 38 is softer, suggesting forward estimate revisions have not been favourable.
The February earnings print is useful context. EXC surged 9.1% on the day after Q4 2025 results and held most of those gains over the following week, rising 6.5%. The reaction at Q3 2025 was far more contained — the stock added under 1%. Those two data points do not form a pattern, but they suggest the stock is capable of a meaningful move on a positive surprise. After the recent week's 2.5% gain, peers broadly tracked sideways to modestly higher: PPL rose 2.3% on the week, EVRG gained 2.1%, while FE and DUK both added just over 1%. EXC slightly outperformed the peer group heading into the print.
Capital Research and Management stands out in the institutional picture — the firm added 26.3 million shares in the latest quarter, bringing its holding to just over 3% of shares outstanding. That is the largest single-quarter addition among the top holders and a notable vote of confidence against the analyst current. BlackRock added 6.2 million shares in the same period. The insider picture is less clean: February 2 saw the CEO and two senior executives receive equity awards and simultaneously sell modest amounts on the open market, typical of award-and-sell sequences and carrying little directional signal.
The key question into May 6 is whether management's commentary on rate-case outcomes and the capital expenditure plan can push back against the Street's reset — or whether the analysts who moved first on April 17–21 were acting on information the print will confirm.
See the live data behind this article on ORTEX.
Open EXC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
